Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

Auxilium Pharmaceuticals, Inc. : and FCB I LLC File Lawsuit Against Watson for Infringement of Testim® Patents

05/24/2012 | 08:58am US/Eastern

MALVERN, Pa., and WILMINGTON, Del., May 24, 2012/PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) ("Auxilium") and FCB I LLC ("FCB") announced today that they filed a lawsuit against Watson Laboratories, Inc. (NV); Watson Pharmaceuticals, Inc.; and Watson Pharma, Inc. (collectively, "Watson") for infringement of FCB's ten patents listed in the U.S. Food and Drug Administration's ("FDA's") Approved Drug Products with Therapeutic Equivalence Evaluations (commonly known as the "Orange Book") as covering Testim® 1% testosterone gel.  The lawsuit was filed in the United States District Court for the District of New Jerseyon May 23, 2012.

Auxilium and FCB filed this lawsuit in response to a notice letter sent by Watson Laboratories, Inc. (NV) regarding its filing with the FDA of Abbreviated New Drug Application ("ANDA") No. 09

1d ago AUXILIUM PHARMACEUTICALS : Results of Operations and Financial Condition, Financ..
1d ago AUXILIUM PHARMACEUTICALS : reports 3Q loss
2d ago AUXILIUM PHARMACEUTICALS : Announces XIAFLEX Now Approved For The Concurrent Tre..
10/22 AUXILIUM PHARMACEUTICALS : FDA approves Auxilium's Xiaflex to treat Dupuytren's ..
10/21 AUXILIUM PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Ex..
10/20 AUXILIUM PHARMACEUTICALS : Announces XIAFLEX Now Approved For The Concurrent Tre..
10/20 AUXILIUM PHARMACEUTICALS : NASDAQ:AUXL) Investor Alert: Investigation of Takeove..
10/19 AUXILIUM PHARMACEUTICALS : SHAREHOLDER ALERT: Brower Piven Launches An Investiga..
10/19 AUXILIUM PHARMACEUTICALS : Pharmaceutical to be Taken Over by Irish Endo Interna..
10/17 AUXILIUM PHARMACEUTICALS : INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the In..
Duration : Period :
Auxilium Pharmaceuticals,  Technical Analysis Chart | AUXL | US05334D1072 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes